— College of Medicine — Department of Internal Medicine — Divisions — Infectious Diseases — Our Faculty — Bradley Britigan, MD

Bradley Britigan, MD

Stokes-Shackleford Professor, Department of Internal Medicine
Dean, College of Medicine, University of Nebraska Medical Center

Phone: 402-559-4204

Dr. Britigan is a physician-scientist and the Stokes-Shackleford Professor and Dean of the UNMC College of Medicine, a position he has held since 2011. From 2014 to 2016 he also served as interim President of Nebraska Medicine.

Dr. Britigan earned his bachelor’s degree at Cornell University in Ithaca, New York, and his medical degree from the University of Southern California. He completed an internal medicine residency at Rhode Island Hospital and infectious diseases fellowship at the University of North Carolina at Chapel Hill. Dr. Britigan joined the University of Nebraska Medical Center from the University of Cincinnati, where he was chair of the department of internal medicine for seven years. Prior to that, he spent 17 years at the University of Iowa, where he was director of infectious diseases and fellowship program director for 11 years. He is board certified in infectious diseases.

Despite his administrative responsibilities as dean, Dr. Britigan remains active in clinical care, research, and all levels of medical education.

Education

Medical School: University of Southern California, 1980
Residency: Internal Medicine, Rhode Island Hospital, 1983
Fellowship: Infectious Disease, University of North Carolina at Chapel Hill School of Medicine, 1987

Patient Care

Clinic Locations: Internal Medicine Clinic at Durham Outpatient Center

Hospital Appointments: Nebraska Medicine; Omaha VA Medical Center

Research

Dr. Britigan’s research focuses on the biology of oxygen-centered free radicals and/or iron metabolism as they relate to host defense/inflammation. Particular emphasis is on the role of these processes in phagocyte biology and the pathogenesis of infection with bacterial pathogens, such as Pseudomonas aeruginosa and Mycobacterium tuberculosis. His most recent work involves the development of gallium-based compounds as antimicrobial agents to address the growing problem of antibiotic resistance. Dr. Britigan’s research has been funded over the years by the National Institutes of Health, the VA and a variety of research foundations and resulted in more than 135 peer-reviewed publications.

Bradley Britigan, MD

Information